Home / Community / News / News

News

11/06/2018 - 8:42am

DTI detects specific changes in the corticospinal tract, reflecting cortical gray matter volume reductions linked to DM1 motor function deficits.

11/06/2018 - 7:35am

Development, validation, and use of CNS clinical outcome assessments in DM1 must consider their interactions with other parameters of patient functioning.

11/01/2018 - 6:23am

A literature review suggests meta-analysis of cognitive studies in DM1 is both feasible and can inform understanding of disease mechanisms and patient management.

10/16/2018 - 8:26am

A new study lends support for a DM biomarker panel based upon patient urine exRNA assays that may serve as a pharmacodynamic biomarker for go/no go decisions in drug development for DM1.

10/16/2018 - 8:19am

A new review looks at the cross-disease evidence for RAN translation’s contributions to pathogenesis.

Partners

ExpansionTherapeutics.png

© Myotonic Dystrophy Foundation. All rights reserved.